Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
COVID is associated with serious illness in mothers and newborns. Findings reinforce need for targeted interventions, including vaccination.
Before they get COVID, people over 65 should have a plan for accessing antiviral treatment.
Berks County, Pennsylvania, is the first community to join a partnership with local public health departments.
Older people, immunocompromised people and those with underlying health conditions can benefit most from additional shots.
The antiviral treatment reduced the risk of hospitalization or death from SARS-CoV-2 Omicron variants in older adults by 44%.
Investigational drug works differently than antibody drugs which are losing effectiveness against the SARS-CoV-2 virus.
Early findings of widespread, long-lasting virus helps inform long COVID research.
A single vaccine dose delivered to nose aims to protect children and adults against COVID.
Updated Pfizer-BioNTech and Moderna bivalent boosters contain spike proteins from the original and BA.4 and BA.5 omicron variants.
COVID-19 test results provide valuable data that public health departments can use to assess needs and modify responses.
COVID can also affect the gut lining, which may allow pathogenic bacteria to enter the bloodstream and cause secondary infections.
These three respiratory illnesses—and others—share many of the same symptoms.
Researchers found that today’s COVID rapid antigen tests can identify all current variants of concern and interest.
The small study found no evidence of delayed development of antibodies in participants who experienced rebound after taking Paxlovid.
Updated boosters could go to the “worried well” who have good insurance rather than to those at highest risk.
Higher levels of viral antigens in the blood correlated with more severe disease.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.